Thermo Fisher Scientific (TMO) Stock: Fresh Deals, Wall Street Upgrades and Long‑Term Outlook as of December 4, 2025
Thermo Fisher shares traded near $573.57 on December 4, 2025, rebounding sharply from mid-year lows. The company announced a new partnership with GENinCode to distribute a coronary heart disease risk test in the US and EMEA. Institutional ownership stands at about 89%. Market cap is around $218 billion, with a forward P/E of 21–25x.